Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The internal bioartifical liver].

S Benoist1, B Nordlinger

  • 1Laboratoire de recherche chirurgicale, INSERM U402, Faculté de médecine Saint Antoine, 27, rue de Chaligny, 75571 Paris.

Journal De La Societe De Biologie
|September 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simple prognostic score to predict recurrence after pancreaticoduodenectomy for ampullary carcinoma: results from the French prospective FFCD-AC cohort.

ESMO open·2024
Same author

[Rectal cancer: Towards personalized medicine].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021
Same author

New treatment strategies for non-metastatic rectal cancer.

Journal of visceral surgery·2021
Same author

Impact of early biochemical diagnosis of anastomotic leakage after rectal cancer surgery: long-term results from GRECCAR 5 trial.

The British journal of surgery·2021
Same author

Surgery and artificial intelligence: Just around the corner?

Journal of visceral surgery·2021
Same author

A Reappraisal of Outcome of Elective Surgery After Successful Non-Operative Management of an Intra-Abdominal Abscess Complicating Ileocolonic Crohn's Disease: A Subgroup Analysis of a Nationwide Prospective Cohort.

Journal of Crohn's & colitis·2020
Same journal

[Food safety of GMOs].

Journal de la Societe de biologie·2010
Same journal

[Placing on the market, breeders rights and growing genetically modified (GM) varieties].

Journal de la Societe de biologie·2010
Same journal

[Cultivation and environmental impacts of GMO crops].

Journal de la Societe de biologie·2010
Same journal

[Applications of genetically modified animals].

Journal de la Societe de biologie·2010
Same journal

[Why GMOs].

Journal de la Societe de biologie·2010
Same journal

[Mutations in renin-angiotensin system genes and kidney developmental anomalies].

Journal de la Societe de biologie·2010
See all related articles

Internal bioartificial livers (IBALs) offer a potential alternative to liver transplantation by using encapsulated hepatocytes. This approach aims to support liver function during native liver regeneration, serving as a bridge to transplant.

Area of Science:

  • Hepatology and Regenerative Medicine
  • Biomaterials and Tissue Engineering

Background:

  • Liver transplantation is a definitive treatment for end-stage liver disease, but donor organ scarcity necessitates alternative strategies.
  • Bioartificial liver devices aim to provide temporary liver support, bridging patients to transplantation or native liver recovery.

Purpose of the Study:

  • To explore the concept and potential of internal bioartificial livers (IBALs) as an alternative to traditional liver transplantation.
  • To investigate the use of encapsulated hepatocytes (allogeneic or xenogeneic) for auxiliary liver support.
  • To establish IBALs as a therapeutic bridge for patients with acute or chronic liver failure and metabolic deficiencies.

Main Methods:

  • Isolation and encapsulation of hepatocytes (potentially from large animal sources for immediate availability).

Related Experiment Videos

  • Implantation of encapsulated hepatocytes within the peritoneal cavity to create an internal bioartificial liver.
  • Evaluation of IBAL function in supporting liver activity until native liver regeneration.

    • Main Results:

    • The study proposes a novel approach using encapsulated hepatocytes for auxiliary liver function.
    • Large animal sources offer a viable option for immediate hepatocyte isolation when IBAL is needed.
    • The peritoneal cavity is identified as a suitable implantation site for IBALs.

    Conclusions:

    • Internal bioartificial livers (IBALs) represent a promising alternative or bridge therapy for liver failure.
    • Encapsulated hepatocytes, sourced from animals, can provide essential liver functions temporarily.
    • IBALs hold potential for treating metabolic disorders and acute/chronic liver failure, reducing reliance on transplantation.